Zhong Ji Longevity Science to Buy 25% Stake in Boutique Stem Cell Center

MT Newswires Live

Dec 02, 2025

Zhong Ji Longevity Science Group (HKG:0767) agreed to acquire 25% interest in Asian Integrated Cell Laboratory from China International Osteoarticular Medical Group for an initial consideration of HK$300 million, a Monday Hong Kong bourse filing said.

Shares of the longevity firm were up nearly 4% in Tuesday afternoon trading.

The consideration for the deal will be satisfied through the issue of non-redeemable convertible bonds.

The bonds will carry no interest rate and will be convertible into a maximum of 545.5 million shares at HK$0.55 apiece.

The target firm operates boutique high-end customized stem cells and IPSC storage center with testing and preclinical immunotherapies services.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2588089465"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2588089465\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2588089465?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 12:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588089465","market":"fut","top_or_hot":-1,"title":"Zhong Ji Longevity Science to Buy 25% Stake in Boutique Stem Cell Center","media":"MT Newswires Live","content":"<html><body><p> Zhong Ji Longevity Science Group (HKG:0767) agreed to acquire 25% interest in Asian Integrated Cell Laboratory from China International Osteoarticular Medical Group for an initial consideration of HK$300 million, a Monday Hong Kong bourse filing said.</p><p>Shares of the longevity firm were up nearly 4% in Tuesday afternoon trading.</p><p>The consideration for the deal will be satisfied through the issue of non-redeemable convertible bonds.</p><p>The bonds will carry no interest rate and will be convertible into a maximum of 545.5 million shares at HK$0.55 apiece.</p><p>The target firm operates boutique high-end customized stem cells and IPSC storage center with testing and preclinical immunotherapies services.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zhong Ji Longevity Science to Buy 25% Stake in Boutique Stem Cell Center</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZhong Ji Longevity Science to Buy 25% Stake in Boutique Stem Cell Center\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-02 12:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Zhong Ji Longevity Science Group (HKG:0767) agreed to acquire 25% interest in Asian Integrated Cell Laboratory from China International Osteoarticular Medical Group for an initial consideration of HK$300 million, a Monday Hong Kong bourse filing said.</p><p>Shares of the longevity firm were up nearly 4% in Tuesday afternoon trading.</p><p>The consideration for the deal will be satisfied through the issue of non-redeemable convertible bonds.</p><p>The bonds will carry no interest rate and will be convertible into a maximum of 545.5 million shares at HK$0.55 apiece.</p><p>The target firm operates boutique high-end customized stem cells and IPSC storage center with testing and preclinical immunotherapies services.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1186","symbol_name":"特殊金融服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2588089465","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588089465","pubTimestamp":1764651597,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Zhong Ji Longevity Science Group  agreed to acquire 25% interest in Asian Integrated Cell Laboratory from China International Osteoarticular Medical Group for an initial consideration of HK$300 million, a Monday Hong Kong bourse filing said.Shares of the longevity firm were up nearly 4% in Tuesday afternoon trading.The consideration for the deal will be satisfied through the issue of non-redeemable convertible bonds.The bonds will carry no interest rate and will be convertible into a maximum of 545.5 million shares at HK$0.55 apiece.The target firm operates boutique high-end customized stem cells and IPSC storage center with testing and preclinical immunotherapies services.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1186":"特殊金融服务","00767":"中基长寿科学"},"translate_title":"中基长寿科学将收购精品干细胞中心25%股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00767":0.9},"content_text":"Zhong Ji Longevity Science Group (HKG:0767) agreed to acquire 25% interest in Asian Integrated Cell Laboratory from China International Osteoarticular Medical Group for an initial consideration of HK$300 million, a Monday Hong Kong bourse filing said.Shares of the longevity firm were up nearly 4% in Tuesday afternoon trading.The consideration for the deal will be satisfied through the issue of non-redeemable convertible bonds.The bonds will carry no interest rate and will be convertible into a maximum of 545.5 million shares at HK$0.55 apiece.The target firm operates boutique high-end customized stem cells and IPSC storage center with testing and preclinical immunotherapies services.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}